Meiji Yasuda Asset Management Co Ltd. Acquires Shares of 6,641 Cigna Group $CI

Key Points

• Meiji Yasuda Asset Management acquired 6,641 shares of Cigna Group in the second quarter, valued at approximately $1.83 million. Institutional investors collectively own 86.99% of CI stock.
• Cigna reported quarterly earnings of $7.78 per share, exceeding estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company maintained fiscal 2026 EPS guidance of approximately $30.45.
• Cigna declared a quarterly dividend of $1.56, equivalent to $6.24 annually and a 2.2% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $339.45, despite several recent downgrades to “Hold.”

Meiji Yasuda Asset Management Co Ltd. acquired a new stake in Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 6,641 shares of the health services provider's stock, valued at approximately $1,831,000.

Several other hedge funds and other institutional investors have also modified their holdings of CI. Wilkerson Advisory Group LLC bought a new stake in Cigna Group in the fourth quarter valued at $25,000. Cedar Mountain Advisors LLC lifted its holdings in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after acquiring an additional 68 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group in the 4th quarter valued at $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group in the 4th quarter worth about $29,000. Institutional investors own 86.99% of the company's stock.

Cigna Group Price Performance

CI opened at $280.32 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a market capitalization of $74.07 billion, a P/E ratio of 11.60, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The company's 50 day simple moving average is $283.92 and its 200-day simple moving average is $281.48. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group's revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is currently 25.82%.

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,677 shares of the company's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 23,012 shares of company stock valued at $6,386,550. Corporate insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CI. Wells Fargo & Company lifted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Royal Bank Of Canada upped their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a research note on Friday, May 1st. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a "buy" rating to a "hold" rating and cut their target price for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Finally, Jefferies Financial Group downgraded Cigna Group from a "buy" rating to a "hold" rating and reduced their target price for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $339.45.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source